跳至主要内容
临床试验/DRKS00008196
DRKS00008196已完成不适用

Prospective registry study investigating medical care in hematooncologic patients with venousthromboembolism in Berlin - GECAT – German Evaluation of Cancer associated Thrombosis

Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie0 个研究点目标入组 382 人开始时间: 2015年5月18日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
382

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
one 至 one(—)
性别
All

入选标准

  • Patients with malignant disease of any kind and newly diagnosed venous thromboembolism who received inpatient or outpatient treatment in the hospitals of Vivantes/Charite. The malignant disease should have been diagnosed or have required treatment during the past two years.Patients with venous thromboembolism in whom malignant disease is diagnosed for the first time, in the course of diagnostic procedures due to venous thrombembolism

排除标准

  • Patients suffering venous thromboembolism but not malignant disease will be registered only once by with reduced baseline documentation. There will be no follow up. They will not take part in follow-up-investigation.

研究者

发起方
Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie

相似试验